| 摘要 |
The invention relates to pharmaceutical industry, namely to combined drugs possessing broncholytic, bronchosecretory, mucolytic and expectorative activities and may be used for treating acute and chronic inflammatory diseases of the respiratory organs such as bronchitis, tracheitis, laryngitis, pharyngitis, pneumonia, bronchiectasis, the bronchial asthma. The broncholytic composition contains Salbutamol as an active ingredient and stearate of the alkaline earth metal as the excipient. Furthermore, the composition contains Mucaltin, Acetylcysteine, Ambroxol hydrochloride, and ascorbic acid as active ingredients and sodium hydrocarbonate, tartaric acid, and the refined sugar as excipients. |
